DEC 23, 2018 11:22 PM PST

Preventive Drug Decreases Cases of Leprosy in Morocco

WRITTEN BY: Nouran Amin

Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect on public health of communities and nations as a whole. Since 1981, the introduction of antibacterial multidrug therapy has significantly decreased cases of leprosy on a worldwide scale. However, some countries like Morocco continue to have transmission of leprosy until the implementation of a new program.

Learn more about leprosy:

Now, cases of leprosy has declined in Morocco by more than 16 percent since 2012. This decline is due to the introduction of program involving a preventative drug according to a report published in PLOS Neglected Tropical Diseases. The drug involves a single dose of rifampicin and was introduced through the Single Dose Rifampicin Chemoprophylaxis (SDRC) program with the goal of decreasing the spread of leprosy through household contacts.

The leprosy cases were analyzed each year between 2000 and 2017 with data involving age, gender, origin, region, and grade of disability of leprosy patients. Results show that between 2000 and 2012, before the SDRC program, the leprosy cases was -4.68% per year. Now, between 2012 and 2017--after implementing SDRC the annual percent change per year was -16.83%.

Outpatients department. Kenitra Hospital.

Credit: Mary Gillham Archive Project, Flickr, CC BY 2.0, 2017 via MedicalXpress

"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.

Source: MedicalXpress

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
NOV 26, 2020
Cannabis Sciences
Women More Likely than Men to Swap Prescription Medication for Cannabis
NOV 26, 2020
Women More Likely than Men to Swap Prescription Medication for Cannabis
The stigma around cannabis usage is fading as cannabis laws become increasingly lax. Now, researchers from DePaul Univer ...
Loading Comments...